|
US4280918A
(en)
|
1980-03-10 |
1981-07-28 |
International Business Machines Corporation |
Magnetic particle dispersions
|
|
GB9509321D0
(en)
|
1995-05-09 |
1995-06-28 |
Zylepsis Ltd |
Methods of and substances for inhibiting oxidative enzymes
|
|
WO1998017667A1
(en)
|
1996-10-18 |
1998-04-30 |
Wayne State University |
6',7'-dihydroxybergamottin, a cytochrome p450 ihnibitor in grapefruit juice
|
|
JPH10120597A
(ja)
|
1996-10-22 |
1998-05-12 |
Eiken Chem Co Ltd |
リンパ節高集積性コロイド粒子
|
|
ATE253357T1
(de)
|
1997-08-19 |
2003-11-15 |
Warner Lambert Co |
Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
|
|
US7311924B2
(en)
*
|
1999-04-01 |
2007-12-25 |
Hana Biosciences, Inc. |
Compositions and methods for treating cancer
|
|
DE60115044T2
(de)
*
|
2000-06-30 |
2006-08-03 |
Inex Pharmaceuticals Corp., Burnaby |
Liposomale antineoplastische arzneimittel und deren verwendungen
|
|
US8178123B2
(en)
|
2001-08-29 |
2012-05-15 |
Femina Pharma Incorporated |
Method for augmentation of intraepithelial and systemic exposure of therapeutic agents having substrate activity for cytochrome P450 enzymes and membrane efflux systems following vaginal and oral cavity administration
|
|
US20050090732A1
(en)
|
2003-10-28 |
2005-04-28 |
Triton Biosystems, Inc. |
Therapy via targeted delivery of nanoscale particles
|
|
JP5513708B2
(ja)
|
2003-12-22 |
2014-06-04 |
ブラッコ・シュイス・ソシエテ・アノニム |
造影イメージング用の気体封入マイクロベシクル・アセンブリー
|
|
US20080193372A1
(en)
*
|
2004-02-10 |
2008-08-14 |
Barnes-Jewish Hospital |
Efficacy and Safety of Targeted Particulate Agents with Decoy Systems
|
|
US20060264804A1
(en)
|
2005-04-07 |
2006-11-23 |
Yoram Karmon |
Device and kit for delivery of encapsulated substances and methods of use thereof
|
|
US20070088414A1
(en)
*
|
2005-05-25 |
2007-04-19 |
Campbell Robert L |
Particulate formulations for intradermal delivery of biologically active agents
|
|
DE102005039579B4
(de)
*
|
2005-08-19 |
2022-06-30 |
Magforce Ag |
Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
|
|
EP2000150B1
(en)
*
|
2006-03-24 |
2016-07-13 |
Toto Ltd. |
Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
|
|
JP2009536151A
(ja)
|
2006-03-30 |
2009-10-08 |
富士フイルム株式会社 |
ナノ粒子
|
|
EP1852107A1
(en)
|
2006-04-19 |
2007-11-07 |
Nanobiotix |
Magnetic nanoparticles compositions and uses thereof
|
|
CA2649870C
(en)
|
2006-05-04 |
2014-07-29 |
University Of South Australia |
Drug release from nanoparticle-coated capsules
|
|
AU2008288917A1
(en)
|
2007-08-21 |
2009-02-26 |
Alza Corporation |
Liposome compositions for in vivo administration of boronic acid compounds
|
|
FR2922106B1
(fr)
|
2007-10-16 |
2011-07-01 |
Univ Claude Bernard Lyon |
Utilisation de nanoparticules a base de lanthanides comme agents radiosensibilisants.
|
|
WO2009081287A2
(en)
|
2007-12-21 |
2009-07-02 |
University Of Guelph |
Polysaccharide nanoparticles
|
|
US9403789B2
(en)
|
2008-02-21 |
2016-08-02 |
Sequoia Pharmaceuticals, Inc. |
Benzofuran-containing amino acid inhibitors of cytochrome P450
|
|
WO2009142754A1
(en)
|
2008-05-22 |
2009-11-26 |
Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dendritic conjugates and methods of use
|
|
EP2130553A1
(en)
|
2008-06-05 |
2009-12-09 |
Nanobiotix |
Inorganic nanoparticles of high density to destroy cells in-vivo
|
|
WO2010048623A2
(en)
|
2008-10-26 |
2010-04-29 |
Board Of Regents, The University Of Texas Systems |
Medical and imaging nanoclusters
|
|
GB0921596D0
(en)
|
2009-12-09 |
2010-01-27 |
Isis Innovation |
Particles for the treatment of cancer in combination with radiotherapy
|
|
JP5649137B2
(ja)
|
2010-02-17 |
2015-01-07 |
国立大学法人神戸大学 |
放射線治療剤
|
|
CN104784121A
(zh)
|
2010-03-26 |
2015-07-22 |
阿布拉科斯生物科学有限公司 |
治疗肝细胞癌的方法
|
|
GB201009455D0
(en)
|
2010-06-04 |
2010-07-21 |
King S College London |
Nanoparticles and their uses in molecular imaging
|
|
US9782342B2
(en)
|
2010-10-11 |
2017-10-10 |
Wichita State University |
Composite magnetic nanoparticle drug delivery system
|
|
BR112013013434A2
(pt)
|
2010-12-17 |
2016-08-16 |
Arrowhead Res Corp |
metade que tem por alvo modulador fármaco cinético em cacho de galactose para sirna
|
|
PL2670394T3
(pl)
|
2011-01-31 |
2019-03-29 |
Nanobiotix |
Układy do dostarczania nanocząstek, ich otrzymywanie i zastosowania
|
|
WO2012104277A2
(en)
|
2011-01-31 |
2012-08-09 |
Nanobiotix |
Method of monitoring the release from liposomes of a product of interest using superparamagnetic nanoparticles.
|
|
US10251841B2
(en)
|
2011-10-17 |
2019-04-09 |
Trustees Of Boston University |
Polymeric depots for localization of agent to biological sites
|
|
CN102532154B
(zh)
|
2012-01-11 |
2014-05-14 |
昆明医学院 |
隆萼当归线型呋喃香豆素化合物及其应用
|
|
US20150209397A1
(en)
|
2012-09-07 |
2015-07-30 |
Carnegie Mellon University |
Methods and materials for reducing reticuloendothelial system clearance of particles from a subject
|
|
ITRM20120480A1
(it)
|
2012-10-09 |
2014-04-10 |
Uni Degli Studi Camerino |
Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione.
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
UA116380C2
(uk)
*
|
2013-05-30 |
2018-03-12 |
Нанобіотікс |
Посилення терапевтичної або профілактичної ефективності фармацевтичної сполуки
|
|
EP2886128A1
(en)
|
2013-12-20 |
2015-06-24 |
Nanobiotix |
Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
|
|
HK1245086A1
(zh)
|
2014-11-25 |
2018-08-24 |
Nanobiotix |
处方药物组成及其制备和使用
|
|
HUE056175T2
(hu)
|
2014-11-25 |
2022-01-28 |
Curadigm Sas |
Gyógyászati készítmények, elõállításuk és alkalmazásaik
|
|
JP6836510B2
(ja)
*
|
2014-11-25 |
2021-03-03 |
キュラディグム・エスアエスＣｕｒａｄｉｇｍ Ｓａｓ |
少なくとも２つの異なるナノ粒子と医薬化合物とを組み合わせた医薬組成物、その調製及び使用
|
|
TW201628656A
(zh)
|
2014-11-25 |
2016-08-16 |
奈諾生技公司 |
醫藥組合物、其製備與用途
|
|
WO2016083331A1
(en)
|
2014-11-25 |
2016-06-02 |
Nanobiotix |
Pharmaceutical composition, preparation and uses thereof
|